AMPK-mediated regulation of endogenous cholesterol synthesis does not affect atherosclerosis in a murine Pcsk9-AAV model.

Atherosclerosis

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; Centre for Infection, Immunity and Inflammation, Ottawa, ON, Canada; Centre for Catalysis Research and Innovation, Ottawa, ON, Canada; Ottawa Institute of Systems Biology, Ottawa, ON, Canada. Electronic address:

Published: October 2024

AI Article Synopsis

  • Dysregulated cholesterol metabolism plays a significant role in atherosclerosis, and the study examines how the AMPK-HMGCR signaling pathway affects cholesterol levels and atherosclerosis development.
  • The research used two types of mice: HMGCR S871A knock-in (KI) mice and wild-type (WT) mice, both fed a high-fat and high-cholesterol diet to induce atherosclerosis, but found no significant differences in atherosclerotic plaque formation between the two.
  • The findings suggest limited impact of AMPK-mediated control on cholesterol synthesis related to atherosclerosis progression, highlighting the need for further investigation into various atherosclerosis models.

Article Abstract

Background And Aims: Dysregulated cholesterol metabolism is a hallmark of atherosclerotic cardiovascular diseases, yet our understanding of how endogenous cholesterol synthesis affects atherosclerosis is not clear. The energy sensor AMP-activated protein kinase (AMPK) phosphorylates and inhibits the rate-limiting enzyme in the mevalonate pathway HMG-CoA reductase (HMGCR). Recent work demonstrated that when AMPK-HMGCR signaling was compromised in an Apoe model of hypercholesterolemia, atherosclerosis was exacerbated due to elevated hematopoietic stem and progenitor cell mobilization and myelopoiesis. We sought to validate the significance of the AMPK-HMGCR signaling axis in atherosclerosis using a non-germline hypercholesterolemia model with functional ApoE.

Methods: Male and female HMGCR S871A knock-in (KI) mice and wild-type (WT) littermate controls were made atherosclerotic by intravenous injection of a gain-of-function Pcsk9-adeno-associated virus followed by high-fat and high-cholesterol atherogenic western diet feeding for 16 weeks.

Results: AMPK activation suppressed endogenous cholesterol synthesis in primary bone marrow-derived macrophages from WT but not HMGCR KI mice, without changing other parameters of cholesterol regulation. Atherosclerotic plaque area was unchanged between WT and HMGCR KI mice, independent of sex. Correspondingly, there were no phenotypic differences observed in hematopoietic progenitors or differentiated immune cells in the bone marrow, blood, or spleen, and no significant changes in systemic markers of inflammation. When lethally irradiated female mice were transplanted with KI bone marrow, there was similar plaque content relative to WT.

Conclusions: Given previous work, our study demonstrates the importance of preclinical atherosclerosis model comparison and brings into question the importance of AMPK-mediated control of cholesterol synthesis in atherosclerosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2024.117608DOI Listing

Publication Analysis

Top Keywords

cholesterol synthesis
16
endogenous cholesterol
12
synthesis atherosclerosis
8
ampk-hmgcr signaling
8
hmgcr mice
8
bone marrow
8
cholesterol
6
atherosclerosis
6
ampk-mediated regulation
4
regulation endogenous
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!